These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6036394)

  • 1. Dissociation between thyroid injury and formation of long-acting thyroid stimulator in thyrotoxicosis.
    Burke G
    Ann Intern Med; 1967 Aug; 67(2):349-55. PubMed ID: 6036394
    [No Abstract]   [Full Text] [Related]  

  • 2. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
    PINCHERA A; PINCHERA MG; STANBURY JB
    J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
    [No Abstract]   [Full Text] [Related]  

  • 3. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
    Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
    Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
    Alford FP; Larkins RG; Martin FI
    Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
    Burke G; Silverstein GE
    JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
    [No Abstract]   [Full Text] [Related]  

  • 6. A COMPARISON OF THE HEAT STABILITY OF LONG-ACTING THYROID STIMULATOR AND HUMAN THYROID-STIMULATING HORMONE.
    MCGIVEN AR; ADAMS DD; PURVES HD
    J Endocrinol; 1965 Apr; 32():29-33. PubMed ID: 14275678
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the relationship between long-acting thyroid stimulator, clinical and biological thyrotoxicosis and exophthalmos.
    Bonnyns M; Demeester-Mirkine N; Calay R; Bastenie PA
    Acta Endocrinol (Copenh); 1968 Aug; 58(4):581-92. PubMed ID: 5695780
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the pathogenesis of the ophthalmopathy of Graves' disease.
    Kriss JP; Pleshakov V; Rosenblum AL; Holderness M; Sharp G; Utiger R
    J Clin Endocrinol Metab; 1967 Apr; 27(4):582-93. PubMed ID: 6071430
    [No Abstract]   [Full Text] [Related]  

  • 9. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR.
    ADAMS DD; KENNEDY TH
    J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical studies of long-acting thyroid stimulator].
    Eguchi Y
    Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thyrotoxicosis].
    Nagata I
    Naika Hokan; 1970 Dec; 17(12):459-77. PubMed ID: 4099951
    [No Abstract]   [Full Text] [Related]  

  • 12. The nucleic acid content of lymphocytes in thyrotoxicosis.
    Smith JF; Glen AC; Greig WR
    Clin Exp Immunol; 1971 Jun; 8(6):911-6. PubMed ID: 5104635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
    Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
    J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
    [No Abstract]   [Full Text] [Related]  

  • 14. The long-acting thyroid stimulator and thyroid disease.
    Kriss JP
    Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the treatment of hyperthyroidism with Iodine-131.
    Torizuka K; Mori T; Konishi J; Morita R; Hamamoto K; Kusakabe T; Miyake T; Fukase M
    J Nucl Med; 1967 May; 8(5):335. PubMed ID: 6032620
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
    Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
    Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum thyroglobulin levels in healthy subjects and in patients with thyroid disease.
    Torrigiani G; Doniach D; Roitt IM
    J Clin Endocrinol Metab; 1969 Mar; 29(3):305-14. PubMed ID: 5773064
    [No Abstract]   [Full Text] [Related]  

  • 18. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
    Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
    Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of a LATS-like response by thyroglobulin in the McKenzie assay system.
    Wood LC; Burger A; Peterson M; Ingbar SH
    Endocrinology; 1973 May; 92(5):1538-43. PubMed ID: 4695433
    [No Abstract]   [Full Text] [Related]  

  • 20. A STANDARD FOR THE LONG-ACTING THYROID STIMULATOR (LATS) IN THE SERUM OF PATIENTS WITH THYROTOXICOSIS.
    DORRINGTON KJ; MUNRO DS
    J Endocrinol; 1964 Nov; 31():21-8. PubMed ID: 14231127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.